期刊文献+

乙型和丙型肝炎病毒核酸检测技术及进展 被引量:20

原文传递
导出
摘要 近年来,病毒性肝炎的实验室诊断领域取得了飞速的进展,新方法、新技术的出现提高了对病毒检测的灵敏度和准确度,使病毒性肝炎的诊断和治疗水平上了一个新的台阶。病毒性肝炎NAT分为两大类,即病毒核酸载量的检测和病毒基因型/基因突变检测。鉴于甲型、丁型和戊型肝炎病毒的检测主要以血清学检测为主,本文主要介绍乙型肝炎与丙型肝炎NAT的主要技术及进展。
作者 杨瑞锋 魏来
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2010年第5期476-480,共5页 Chinese Journal of Laboratory Medicine
  • 相关文献

参考文献17

  • 1Liaw YF.2008 APASL guidelines for HBV management// The 18th conference of the Asian Pacific Association of the Liver,Seoul,2008[S/OL].[2008-12-20].http://www.apasl.info/guidelinesHBV.html. 被引量:1
  • 2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 3Yao JD,Beld MG,Oon LL,et al.Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay.J Clin Microbiol,2004,42:800-806. 被引量:1
  • 4Werle-Lapostolle B,Bowden S,Locamini S,et al.Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.Gastroenterology,2004,126:1750-1758. 被引量:1
  • 5Degertekin B,Lok AS.Monitoring antiviral resistance in patients receiving nucleos(t) ide analog therapies for hepatitis B:which method should be used.J Hepatol,2008,48:892-894. 被引量:1
  • 6Solmone M,Vincenti D,Prosperi MC,et al.Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen.J Virol,2009,83:1718-1726. 被引量:1
  • 7Funk ML,Rosenberg DM,Lok AS.World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore an d core promoter variants.J Viral Hepat,2002,9:52 -61. 被引量:1
  • 8Toan NL,Songle H,Kremsner PG,et al.Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam.Hepatology,2006,43:1375-1384. 被引量:1
  • 9Morishima C,Morgan TR,Everhart JE,et al.HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.Hepatology,2006,44:360-367. 被引量:1
  • 10Hadziyannis SJ,Sette H Jr,Morgan TR,et al.Peginterferon-α 2a and ribavirin combination therapy in chronic hepatitis C.Ann Intern Med,2004,140:346-355. 被引量:1

二级参考文献17

共引文献1946

同被引文献124

引证文献20

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部